FDA Approves Revlimid (lenalidomide) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma
Lenalidomide (Revlimid) EP 0925294; US 5635517; WO 9803502,Drugs Fut 2003, 28, 5, 425.Bioorg Med Chem Lett 1999, 9, 11, 1625 RS )-3-(4-amin...
Green chemistry has ecological, financial benefits for Pfizer
When people hear the word "green" these days, they automatically think "environmentally friendly." But among chemists at...
Ordinary Measures : Everything I needed to know I learned in Freshman Chemistry 101
For Years, pharma has been the villain in most public opinion polls. But now, the tide seems to be turning. Last month brought buzz ab...
Pale People May Need Vitamin D Supplements
Researchers at the University of Leeds, funded by Cancer Research UK, suggest that people with very pale skin may be unable to spend enough ...
Researchers Discover Genes Involved in Colorectal Cancer
A jumping gene with the fairy tale name "Sleeping Beauty" has helped to unlock vital clues for researchers investigating the genet...
Using Viagra to Combat Malignant Melanoma
At first it sounds like good news: The body's own immune system gets active in almost every cancer - however, not necessarily for the be...
Popular Posts
Facebook Badge
